$LFT
Lument Finance Trust, Inc. Stock $lft

$lft Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000162828021009741 Filed on May 11, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$7.470M	$9.194M
YoY Change	-18.75%	-7.9%
Cost Of Revenue	$2.960M	$5.020M
YoY Change	-41.04%	-13.15%
Gross Profit	$4.520M	$4.180M
YoY Change	8.13%	19.43%
Gross Profit Margin	60.51%	45.46%
Selling, General & Admin	$1.760M	$1.870M
YoY Change	-5.88%	-28.35%
% of Gross Profit	38.94%	44.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.790M	$2.167M
YoY Change	-17.4%	-18.16%
Operating Profit	$2.730M	$2.013M
YoY Change	35.62%	136.27%
Interest Expense	-$20.00K	$5.018M
YoY Change	-100.4%	-13.12%
% of Operating Profit	-0.73%	249.28%
Other Income/Expense, Net		-$684.0K
YoY Change		365.31%
Pretax Income	$2.820M	$1.330M
YoY Change	112.03%	-5.67%
Income Tax	$14.71K	-$226.5K
% Of Pretax Income	0.52%	-17.03%
Net Earnings	$2.809M	$1.552M
YoY Change	81.01%	5.2%
Net Earnings / Revenue	37.6%	16.88%
Basic Earnings Per Share	$0.11
Diluted Earnings Per Share	$0.11	$62.22K
COMMON SHARES
Basic Shares Outstanding	24.94M shares	24.91M shares
Diluted Shares Outstanding	24.94M shares	24.91M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.70M	$11.30M
YoY Change	3.54%	-16.91%
Cash & Equivalents	$11.72M	$11.33M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$48.40M	$13.70M
YoY Change	253.28%	-15.43%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$32.20M	$6.900M
YoY Change	366.67%	-86.86%
Total Long-Term Assets	$519.0M	$650.3M
YoY Change	-20.19%	1.11%
TOTAL ASSETS
Total Short-Term Assets	$48.40M	$13.70M
Total Long-Term Assets	$519.0M	$650.3M
Total Assets	$567.4M	$664.0M
YoY Change	-14.55%	0.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$300.0K	$700.0K
YoY Change	-57.14%	-73.08%
Accrued Expenses	$400.0K	$600.0K
YoY Change	-33.33%	-40.0%
Deferred Revenue
YoY Change
Short-Term Debt	$409.4M	$506.4M
YoY Change	-19.15%	0.38%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$413.6M	$510.6M
YoY Change	-19.0%	-0.04%
LONG-TERM LIABILITIES
Long-Term Debt	$39.60M	$39.40M
YoY Change	0.51%	0.25%
Other Long-Term Liabilities	$300.0K	$700.0K
YoY Change	-57.14%	-73.08%
Total Long-Term Liabilities	$39.60M	$39.40M
YoY Change	0.51%	0.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$413.6M	$510.6M
Total Long-Term Liabilities	$39.60M	$39.40M
Total Liabilities	$453.1M	$550.0M
YoY Change	-17.6%	-0.03%
SHAREHOLDERS EQUITY
Retained Earnings	$13.67M	$3.962M
YoY Change	245.0%	-267.6%
Common Stock	$249.4K	$249.3K
YoY Change	0.02%	5.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$114.2M	$114.0M
YoY Change
Total Liabilities & Shareholders Equity	$567.4M	$664.0M
YoY Change	-14.55%	0.7%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$2.809M	$1.552M
YoY Change	81.01%	5.2%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$3.172M	$2.372M
YoY Change	33.74%	-5.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$28.64M	-$4.110M
YoY Change	-796.84%	-157.16%
Cash From Investing Activities	$28.64M	-$4.106M
YoY Change	-797.56%	-157.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$5.747M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$57.32M	$3.970M
YoY Change	-1543.57%	-236.31%
NET CHANGE
Cash From Operating Activities	$3.172M	$2.372M
Cash From Investing Activities	$28.64M	-$4.106M
Cash From Financing Activities	-$57.32M	$3.970M
Net Change In Cash	-$25.50M	$2.237M
YoY Change	-1240.28%	-66.99%
FREE CASH FLOW
Cash From Operating Activities	$3.172M	$2.372M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001547546
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-35845
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	LUMENT FINANCE TRUST, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-4966519
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	230 Park Avenue, 23rd Floor
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10169
CY2021Q1	dei	City Area Code CityAreaCode	212
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	521-6323
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24943383	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11717804	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11375960	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	32154188	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	57999396	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	484165249	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	547345334	USD
CY2021Q1	oaks	Mortgage Service Rights At Fair Value MortgageServiceRightsAtFairValue	899223	USD
CY2020Q4	oaks	Mortgage Service Rights At Fair Value MortgageServiceRightsAtFairValue	919678	USD
CY2021Q1	us-gaap	Interest Receivable InterestReceivable	2173007	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	2015617	USD
CY2021Q1	oaks	Paydown Receivable PaydownReceivable	34539187	USD
CY2020Q4	oaks	Paydown Receivable PaydownReceivable	0	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	1757914	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	1833794	USD
CY2021Q1	us-gaap	Assets Assets	567406572	USD
CY2020Q4	us-gaap	Assets Assets	621489779	USD
CY2021Q1	oaks	Collateralized Loan Obligations CollateralizedLoanObligations	409404872	USD
CY2020Q4	oaks	Collateralized Loan Obligations CollateralizedLoanObligations	463060090	USD
CY2021Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	39598532	USD
CY2020Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	39556198	USD
CY2021Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	393130	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	432936	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2248612	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3242640	USD
CY2021Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1204688	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1156340	USD
CY2021Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	290670	USD
CY2020Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	338423	USD
CY2021Q1	us-gaap	Liabilities Liabilities	453140504	USD
CY2020Q4	us-gaap	Liabilities Liabilities	507786627	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24943383	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24943383	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	249389	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	249389	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	233853156	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	233850271	USD
CY2021Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	133604590	USD
CY2020Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	131355978	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	13668613	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10859970	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	114166568	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-300926	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	113603652	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	99500	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	99500	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114266068	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	113703152	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	567406572	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	621489779	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	7470117	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	9165805	USD
CY2021Q1	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper	4300	USD
CY2020Q1	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper	28167	USD
CY2021Q1	oaks	Interest Expense Collateralized Loan Obligations InterestExpenseCollateralizedLoanObligations	2185242	USD
CY2020Q1	oaks	Interest Expense Collateralized Loan Obligations InterestExpenseCollateralizedLoanObligations	4237889	USD
CY2021Q1	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	771865	USD
CY2020Q1	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	780441	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4517310	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4175642	USD
CY2021Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-20455	USD
CY2020Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-877749	USD
CY2021Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	124156	USD
CY2020Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	194147	USD
CY2021Q1	us-gaap	Other Income OtherIncome	0	USD
CY2020Q1	us-gaap	Other Income OtherIncome	2	USD
CY2021Q1	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	103701	USD
CY2020Q1	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-683600	USD
CY2021Q1	oaks	Management And Incentive Fees ManagementAndIncentiveFees	720999	USD
CY2020Q1	oaks	Management And Incentive Fees ManagementAndIncentiveFees	584821	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	680314	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	765892	USD
CY2021Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	312454	USD
CY2020Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	461121	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-34753	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	49135	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54132	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	1797655	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	2166892	USD
CY2021Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	2823356	USD
CY2020Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1325150	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14713	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-226521	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2808643	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1551671	USD
CY2021Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3708	USD
CY2020Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3750	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2804935	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1547921	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2804935	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1547921	USD
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24943383	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24911483	shares
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.11
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.06
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.09
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.08
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	113703152	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2021Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	2885	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2808643	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2808643	USD
CY2021Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2244904	USD
CY2021Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3708	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114266068	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	108644712	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5747375	USD
CY2020Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	13333	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	7882	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1551671	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1870416	USD
CY2020Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3750	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114064141	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2808643	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1551671	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-207767	USD
CY2020Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-273188	USD
CY2021Q1	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	0	USD
CY2020Q1	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	-13333	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	253254	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	256069	USD
CY2021Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-20455	USD
CY2020Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-877749	USD
CY2021Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	2885	USD
CY2020Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	7882	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	157390	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	81404	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-13333	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-75880	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	582432	USD
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-39806	USD
CY2020Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-241020	USD
CY2021Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	48348	USD
CY2020Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	21019	USD
CY2021Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-47753	USD
CY2020Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	289276	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3172283	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2371998	USD
CY2021Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	34888000	USD
CY2020Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	38613756	USD
CY2021Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	98068085	USD
CY2020Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	34507879	USD
CY2021Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	34539187	USD
CY2020Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	28640898	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4105877	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5747375	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3242640	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1776912	USD
CY2021Q1	oaks	Payment Of Collateralized Loan Obligations PaymentOfCollateralizedLoanObligations	54073905	USD
CY2020Q1	oaks	Payment Of Collateralized Loan Obligations PaymentOfCollateralizedLoanObligations	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-57316545	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3970463	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25503364	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2236584	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69375356	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16011830	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43871992	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18248414	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	2535893	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	4730094	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2248612	USD
CY2020Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1874166	USD
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. As of March 31, 2021, the novel coronavirus, or COVID-19, pandemic is ongoing. During 2020, the COVID-19 pandemic created disruption in global supply chains, increased rates of unemployment and adversely impacted many industries, including industries related to the collateral underlying certain of our loans. In 2021, the global economy has, with certain setbacks, begun reopening and wider distribution of vaccines will likely encourage greater economic activity. Nonetheless, the recovery could remain uneven, particularly given uncertainty with respect to the distribution and acceptance of the vaccines and their effectiveness with respect to new variants of the virus. We believe the estimates and assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of March 31, 2021, however uncertainty over the ultimate impact of COVID-19 on the global economy generally, and our business in particular, makes any estimates and assumptions as of March 31, 2021 inherently less certain than they would be absent the current and potential impacts of COVID-19. Actual results could differ from our estimates and the differences may be material.</span></div>
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11717804	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11375960	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43871992	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69375356	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	0	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	0	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	USD
CY2021Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	1017419	USD
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24943383	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24943383	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24943383	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24943383	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	USD
CY2021Q1	oaks	One Month Libor Rate OneMonthLIBORRate	0.0011	USD
CY2020Q4	oaks	One Month Libor Rate OneMonthLIBORRate	0.0014	USD
CY2021Q1	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0154	USD
CY2020Q4	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0164	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	484165249	USD
CY2021Q1	oaks	Average Risk Rate AverageRiskRate	2.7
CY2020Q4	oaks	Average Risk Rate AverageRiskRate	3.1
CY2018Q2	oaks	Number Of Loan Participations NumberOfLoanParticipations	8	Loan_Participation
CY2019Q1	oaks	Collateralized Loan Obligation Unamortized Discount CollateralizedLoanObligationUnamortizedDiscount	39200000	USD
CY2021Q1	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	651468	USD
CY2020Q4	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	693802	USD
CY2021Q1	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2020Q4	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2020Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2021Q1	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2020Q4	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2020Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2021Q1	oaks	Number Of Licensed Sub Servicers NumberOfLicensedSubServicers	2	numberOfMortgageSub-servicers
CY2021Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	899223	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	919678	USD
CY2020Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	39556198	USD
CY2019	oaks	Management Fee Percentage ManagementFeePercentage	0.015
CY2019	oaks	Quarterly Management Fee Percentage QuarterlyManagementFeePercentage	0.00375
CY2021Q1	us-gaap	Management Fee Expense ManagementFeeExpense	588767	USD
CY2020Q1	us-gaap	Management Fee Expense ManagementFeeExpense	584821	USD
CY2021Q1	us-gaap	Management Fee Payable ManagementFeePayable	588000	USD
CY2020Q1	us-gaap	Management Fee Payable ManagementFeePayable	566000	USD
CY2021Q1	oaks	Incentive Fees IncentiveFees	132232	USD
CY2020Q1	oaks	Incentive Fees IncentiveFees	0	USD
CY2021Q1	oaks	Incentive Fees Payable IncentiveFeesPayable	132232	USD
CY2020Q1	oaks	Incentive Fees Payable IncentiveFeesPayable	0	USD
CY2021Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	312454	USD
CY2020Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	461121	USD
CY2021Q1	oaks	Reimbursable Costs Payable ReimbursableCostsPayable	311879	USD
CY2020Q1	oaks	Reimbursable Costs Payable ReimbursableCostsPayable	447000	USD
CY2021Q1	oaks	Exit Fee Waived Percentage Reduced ExitFeeWaivedPercentageReduced	0.50
CY2021Q1	oaks	Reimbursable Operating Expense Waived ReimbursableOperatingExpenseWaived	129120	USD
CY2020Q1	oaks	Reimbursable Operating Expense Waived ReimbursableOperatingExpenseWaived	0	USD
CY2021Q1	oaks	Fair Value Investments Entities That Calculate Net Asset Value Per Share Funded FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareFunded	6900000	USD
CY2021Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments	10200000	USD
CY2021Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2244904	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1870416	USD
CY2021Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3708	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24943383	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24943383	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24943383	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2808643	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1551671	USD
CY2020Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3750	USD
CY2021Q1	us-gaap	Dividends Dividends	2248612	USD
CY2020Q1	us-gaap	Dividends Dividends	1874166	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	560031	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-322495	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24938883	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24906983	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4500	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4500	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24943383	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24911483	shares

Files In Submission

Name	View Source	Status
0001628280-21-009741-index-headers.html	Edgar Link	pending
0001628280-21-009741-index.html	Edgar Link	pending
0001628280-21-009741.txt	Edgar Link	pending
0001628280-21-009741-xbrl.zip	Edgar Link	pending
a20210331exhibit3-1.htm	Edgar Link	pending
a20210331exhibit31-1.htm	Edgar Link	pending
a20210331exhibit31-2.htm	Edgar Link	pending
a20210331exhibit32-1.htm	Edgar Link	pending
a20210331exhibit32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_01a.jpg	Edgar Link	pending
image_101a.jpg	Edgar Link	pending
image_11a.jpg	Edgar Link	pending
image_131a.jpg	Edgar Link	pending
image_141a.jpg	Edgar Link	pending
image_151a.jpg	Edgar Link	pending
image_161a.jpg	Edgar Link	pending
image_171a.jpg	Edgar Link	pending
image_181a.jpg	Edgar Link	pending
image_191a.jpg	Edgar Link	pending
image_201a.jpg	Edgar Link	pending
image_211a.jpg	Edgar Link	pending
image_21a.jpg	Edgar Link	pending
image_221a.jpg	Edgar Link	pending
image_261a.jpg	Edgar Link	pending
image_271a.jpg	Edgar Link	pending
image_291a.jpg	Edgar Link	pending
image_301a.jpg	Edgar Link	pending
image_311a.jpg	Edgar Link	pending
image_31a.jpg	Edgar Link	pending
image_321a.jpg	Edgar Link	pending
image_331a.jpg	Edgar Link	pending
image_341a.jpg	Edgar Link	pending
image_351a.jpg	Edgar Link	pending
image_361a.jpg	Edgar Link	pending
image_371a.jpg	Edgar Link	pending
image_381a.jpg	Edgar Link	pending
image_401.jpg	Edgar Link	pending
image_421.jpg	Edgar Link	pending
image_431.jpg	Edgar Link	pending
image_491a.jpg	Edgar Link	pending
image_511.jpg	Edgar Link	pending
image_561.jpg	Edgar Link	pending
image_591a.jpg	Edgar Link	pending
image_601a.jpg	Edgar Link	pending
image_611a.jpg	Edgar Link	pending
image_61a.jpg	Edgar Link	pending
image_621a.jpg	Edgar Link	pending
image_631a.jpg	Edgar Link	pending
image_641a.jpg	Edgar Link	pending
image_651a.jpg	Edgar Link	pending
image_661a.jpg	Edgar Link	pending
image_761a.jpg	Edgar Link	pending
image_781a.jpg	Edgar Link	pending
image_791a.jpg	Edgar Link	pending
image_91a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oaks-20210331.htm	Edgar Link	pending
oaks-20210331.xsd	Edgar Link	pending
oaks-20210331_cal.xml	Edgar Link	unprocessable
oaks-20210331_def.xml	Edgar Link	unprocessable
oaks-20210331_g1.jpg	Edgar Link	pending
oaks-20210331_htm.xml	Edgar Link	completed
oaks-20210331_lab.xml	Edgar Link	unprocessable
oaks-20210331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFT
Lument Finance Trust, Inc. Stock $lft

2021 Q1 Form 10-Q Financial Statement

#000162828021009741 Filed on May 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT Lument Finance Trust, Inc. Stock $lft

2021 Q1 Form 10-Q Financial Statement

#000162828021009741 Filed on May 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT
Lument Finance Trust, Inc. Stock $lft